Brian Lian
President & CEO at Viking Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Viking Therapeutics Inc. | Open-market sale | โ148,517 | $33.32 | $4,947,888 |
| Jul 28, 2026 | Viking Therapeutics Inc. | Grant or award | +221,667 | โ | โ |
| Jan 5, 2026 | Viking Therapeutics Inc. | Open-market sale | โ132,454 | $32.29 | $4,276,940 |
| Jan 5, 2026 | Viking Therapeutics Inc. | Open-market sale | โ53,279 | $33.38 | $1,778,453 |
| Jan 5, 2026 | Viking Therapeutics Inc. | Open-market sale | โ41,276 | $34.22 | $1,412,465 |
| Jan 5, 2026 | Viking Therapeutics Inc. | Open-market sale | โ6,400 | $35.07 | $224,448 |
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +78,400 | โ | โ |
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +224,080 | โ | โ |
| Oct 28, 2025 | Viking Therapeutics Inc. | Open-market sale | โ38,989 | $35.01 | $1,365,005 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +70,084 | โ | โ |
| Jul 3, 2025 | Viking Therapeutics Inc. | Open-market sale | โ26,889 | $27.80 | $747,514 |
| Jul 2, 2025 | Viking Therapeutics Inc. | Grant or award | +48,333 | โ | โ |
| Jan 6, 2025 | Viking Therapeutics Inc. | Open-market sale | โ175,490 | $42.68 | $7,489,913 |
| Jan 6, 2025 | Viking Therapeutics Inc. | Open-market sale | โ19,000 | $43.32 | $823,080 |
| Jan 3, 2025 | Viking Therapeutics Inc. | Grant or award | +92,800 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.